Peer-reviewed veterinary case report
Low molecular weight heparin use and blood clot risk in 57 cats
By Smith, Caren E et al.·Published in Journal of the American Veterinary Medical Association·2004·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of low molecular weight heparin in cats: 57 cases (1999-2003).
- Species:
- cat
Plain-English summary
Fifty-seven cats were treated with a blood thinner called dalteparin to see how well it worked and if there were any side effects. Owners found it easy to give the medication, which was typically given once or twice a day. While bleeding issues were rare, some cats with heart disease developed blood clots despite treatment. Overall, dalteparin was well tolerated, but more research is needed to determine if it effectively prevents blood clots in cats.
People also search for: cat blood thinner side effects · dalteparin for cats · cat heart disease treatment
Abstract
OBJECTIVE: To determine duration of administration, complications, and frequency of aortic thromboembolism associated with administration of low molecular weight heparin (dalteparin) in cats. DESIGN: Retrospective study. ANIMALS: 57 cats treated with dalteparin PROCEDURE: Data were recorded from the medical records of cats treated with dalteparin, and owners were contacted by telephone for information regarding ease of administration and possible adverse effects. RESULTS: Dalteparin was easily administered by owners. Median dose was 99 U/kg (45 U/lb) once or twice daily. Bleeding complications were infrequent. Of 43 cats with cardiomyopathy that received owner-administered dalteparin for a median follow-up time of 172 days, 8 cats developed documented or possible arterial thromboembolism. CONCLUSIONS AND CLINICAL RELEVANCE: Dalteparin was easily administered by owners and was well tolerated by cats. Whether dalteparin administration can reduce the frequency or severity of arterial thromboembolism is not yet known.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15521447/